P. aeruginosa is one of the most important pathogen that causes nosocomial infections often acquired from hospital environment and contaminated medical devices. The infections caused by this bacterium are particularly problematic because it is inherently resistant to several unrelated antimicrobial agents and antiseptics. Hence, the aim of this study was to determine drug resistance and disinfectants susceptibility of P. aeruginosa isolated from clinical samples and hospital environments. A laboratory based cross sectional study was conducted from May to September, 2012 on a total of 81 P. aeruginosa isolates. A standard bacteriological technique (conventional biochemical tests and pigment production) was used to identify the bacterium. Drug resistance and disinfectant susceptibility tests were determined by Kirby-Bauer disc-diffusion and through the classic method of successive dilutions respectively. In this study a total of 305 (160 clinical and 145 environmental) samples were investigated for P. aeruginosa and 81 isolates were obtained. This gives an overall P. aeruginosa isolation rate of 26.5% (81/305). About 47.5% of the clinical and 34.2% environmental isolates were detected from wounds and ward sinks respectively. Of these P. aeruginosa isolates, 95.1% were resistance to Trimethoprim-sulphametoxazole, 62% to Gentamicin, and 58% to Ceftriaxone. But, only 4.9% of isolates were resistance to Amikacin. Moreover, disinfectant susceptibility test revealed that hydrogen peroxide and sodium hypochlorite had a higher (92.6% & 91.4%) bactericidal activity compared to ethanol and savlon at the recommended user dilution. In general, our results indicated that P. aeruginosa was significantly resistance to commonly prescribed antimicrobial drugs, a situation that demands a more rational and appropriate use of antibiotics. Hydrogen peroxide and sodium hypochlorite were relatively more effective when used in recommended dilution. However, all tested disinfectants or antiseptics showed reduced bactericidal activities in higher dilutions. Therefore, strict adherence to the recommended dilution is important for better activity. The correct use of them also has to be considered appropriately as part of infection control practices.
Published in | American Journal of Biomedical and Life Sciences (Volume 2, Issue 2) |
DOI | 10.11648/j.ajbls.20140202.12 |
Page(s) | 40-45 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2014. Published by Science Publishing Group |
P. aeruginosa, Drug resistance, Disinfectant susceptibility, Clinical and Environmental samples, Jimma
[1] | Ndip RN, Dilonga HM, Ndip LM, Akoachere JF, Akenji TN. Pseudomonas aeruginosa isolates re-covered from clinical and environmental samples in Buea, Cameroon: current status on biotyping and antibiogram. Trop Med Int Health 2005; 10: 74-81. |
[2] | Strateva T, Raykova VO, Markova B, Todorova A, Proevska YM, Mitov I. Problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria: current status of antimicrobial resistance and prevailing resistance mechanisms. J Med Microbiol 2007; 56: 956–963. |
[3] | Meenakumari S, Verma Sh, Absar A, Chaudhary A. Antimicrobial susceptibility pattern of clinical isolates of Pseu-domonas aeruginosa in an Indian cardiac hospital. Int J Engin Sci Technol 2011; 3: 7117- 7124. |
[4] | Orsi GB, Tomao P, Visca P. In vitro activity of commercially manufactured disinfec-tants against Pseudomonas aeruginosa. Eur J Epidemiol 1995; 11: 453-457. |
[5] | Kamel GM, Eldeen NA, Yousef M, Ezzat RF. Susceptibility pattern of Pseudomonas aeruginosa against antimi-crobial agents and some plant extracts with focus on its prevalence in different sources. Global Veterinaria 2011; 6: 61-67. |
[6] | Haghi M, Maadi H, Delshad R, Nezhady M, Golizade S. An-tibiotic resistance pattern of Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa isolated from burnt patients Urmia, Iran. Int J Acad Res 2010; 2: 377- 380. |
[7] | Ogbulie JN, Adieze IE, Nwankwo NC. Susceptibilty pattern of some clinical bacterial isolates to selected antibiotics and disinfectants. Polish J Microbiol 2008; 57: 199-204. |
[8] | Romao CM, Faria YN, Pereira L, Asensi M. Susceptibility of clinical isolates of multiresistant Pseudomonas aeruginosa to a hospital disinfectant and molecular typing. Mem Inst Oswaldo Cruz 2005; 10: 541-548. |
[9] | Pal RB, Rodrigues M, Datta S. Role of Pseudomonas in nosocomial infections and biological characterization of local strains. J Biosci Tech 2010; 1: 170-179. |
[10] | World Health Organization. Antimicrobial resistance monitoring programme. WHO Drug Information 1997; 11; 248-249. |
[11] | Hawkey PM. Action against antibiotic resistance: no time to lose. Lancet 1998; 351: 1298-1299. |
[12] | Negussie D, Mesfin N. Review of maternal death in Jimma University Specialized Hospital. Ethiop J Health Sci 2009; 19: 9-12. |
[13] | Cheesbrough M. District Laboratory Practice in Tropical Countries Part II. 2nd ed. Cambridge University Press, Cambridge, 2006. 63–70. |
[14] | Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 20th informational supplement (M100-S20). Wayne, PA; 2010. |
[15] | Mazzola PG, Jozala AF, Novaes LC, Moriel P, Penna TC. Minimal inhibitory concen-tration (MIC) determination of disinfectant and/or sterilizing agents. Braz J Pharm Sci 2009; 45: 241-248. |
[16] | Gad GF, El-Domany RA, Zaki S, Ashour HM. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibi-ogram and resistance mechanisms. J Antimicrob Chemother 2007; 60: 1010–1017. |
[17] | Tekie K. Surgical wound infection in Tikur Anbessa hospital with special emphasis on Pseudomonas ae-ruginosa. MSc Thesis. 2008. |
[18] | Rashid A, Chowdhury A, Rahman HZ, Begum SA, Muazzam N. Infections by Pseudomonas aeruginosa and antibiotic resistance pattern of the isolates from Dhaka Medical College Hospital. Bangladesh J Med Microbiol 2007; 1: 48-51. |
[19] | Okon KO, Agukwe PC, Oladosu W, Balogun ST, Uba A. Antibiotic resistance pattern of Pseudomonas aeru-ginosa isolated from clinical specimens in a tertiary hospital in northeastern Nigeria. Internet J Microbiol 2010; 8: 316-321. |
[20] | Rakesh MR, Govind LN, Kalpesh M, Rosy P, Kanu P, Vegad MM. Antibiotic resistance pattern in Pseudomonas aeruginosa species isolated at a Tertiary Care Hospital, Ahmadabad. National J Med Res 2012; 2: 156-159. |
[21] | Gonlugur U, Bakici MZ, Ozdemir L, Akkurt I, Icagasioglu S, Gultekin F. Retrospective analysis of antibiotic susceptibility patterns of respiratory isolates of Pseudomonas aeruginosa in a Turkish University Hospital. Ann Clin Microbiol Antimicrob 2003; 2:5. |
[22] | Brown PD, Izundu A. Antibiotic resistance in clinical isolates of Pseudomonas aeruginosa in Jamaica. Am J Pub Health 2004; 16: 125–30. |
[23] | George DF. Antibiotic resistance patterns of Pseudomonas aeruginosa and Escherichia coli isolates from three hospitals in Kumasi, Ghana. MSc thesis. 2011. |
[24] | Jombo GT, Jonah P, Ayeni A. Multidrug resistant Pseudomonas aeruginosa in contemporary medical practice: findings from urinary isolates at a Nigerian University Teaching Hospital. Nigerian J Phy-siological Sci 2008; 23: 105-109. |
[25] | Hashemi SH, Mamani M, Omidi J, Niayesh A. Nosocomial bacterial infections and their antimicrobial resistance patterns in university hospitals of Hamedan, Iran. JRHS 2010; 10: 54-58. |
[26] | Masaadeh HA, Jaran AS. Incident of Pseudomonas aeruginosa in post-operative wound infection. Am J Infect Dis 2009; 5: 1-6. |
[27] | Salih HA, Abdulbary M, Abdulrida AS. Susceptibility of Pseudomonas aeruginosa isolated from urine to some antibiotics. J Vet Med Sci 2011; 10: 33-36. |
[28] | Al-Kabsi AM, Yusof M, Sekaran Sh. Antimicrobial resistance pattern of clinical isolate of Pseudomonas aeruginosa in the University of Malaya Medical Center, Malaysia. Afr J Microbiol Res 2011; 5: 5266-5272. |
[29] | Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2005; 49: 479- 487. |
[30] | Mohammadi-mehr M, Feizabadi MM. Antimicrobial resistance pattern of Gram-negative bacilli isolated from patients at ICUs of Army hospitals in Iran. Iran J Microbiol 2011; 3: 26-30. |
[31] | Afifi AM, Moati A, Jarosha Kh, Samaha AS, Jadba AN. Nosocomial infec-tions due to multidrug resistant Pseudomonas aeruginosa. J Al Azhar University 2007; 9: 1-12. |
[32] | Ekizoglu MT, Özalp M, Sultan N, Gür D. An investigation of the bactericidal effect of certain antiseptics and disinfectants on some hospital isolates of Gram-negative bacteria. Infect Control Hosp Epidemiol 2003; 24: 224-226. |
[33] | McDonnell G, Russell AD. Antiseptics and Disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999; 12: 147-179. |
[34] | Bouzada ML, Silva VL, Moreira FA, Silva GA, Diniz CG. Antimicrobial resistance and disinfectants susceptibility of persistent bacteria in a tertiary care hospital. J. Microbiol Antimicrob 2010; 2: 105-112. |
[35] | Iroha IR, Oji AE, Nwosu OK, Amadi ES. Antimicrobial activity of Savlon, Izal and Z-germicide against clinical isolates of Pseudomonas aeruginosa from hospital wards. Eur J Dent Med 2011; 3: 32-35. |
APA Style
Meseret Mitiku, Solomon Ali, Gebre Kibru. (2014). Antimicrobial Drug Resistance and Disinfectants Susceptibility of Pseudomonas aeruginosa Isolates from Clinical and Environmental Samples in Jimma University Specialized Hospital, Southwest Ethiopia. American Journal of Biomedical and Life Sciences, 2(2), 40-45. https://doi.org/10.11648/j.ajbls.20140202.12
ACS Style
Meseret Mitiku; Solomon Ali; Gebre Kibru. Antimicrobial Drug Resistance and Disinfectants Susceptibility of Pseudomonas aeruginosa Isolates from Clinical and Environmental Samples in Jimma University Specialized Hospital, Southwest Ethiopia. Am. J. Biomed. Life Sci. 2014, 2(2), 40-45. doi: 10.11648/j.ajbls.20140202.12
AMA Style
Meseret Mitiku, Solomon Ali, Gebre Kibru. Antimicrobial Drug Resistance and Disinfectants Susceptibility of Pseudomonas aeruginosa Isolates from Clinical and Environmental Samples in Jimma University Specialized Hospital, Southwest Ethiopia. Am J Biomed Life Sci. 2014;2(2):40-45. doi: 10.11648/j.ajbls.20140202.12
@article{10.11648/j.ajbls.20140202.12, author = {Meseret Mitiku and Solomon Ali and Gebre Kibru}, title = {Antimicrobial Drug Resistance and Disinfectants Susceptibility of Pseudomonas aeruginosa Isolates from Clinical and Environmental Samples in Jimma University Specialized Hospital, Southwest Ethiopia}, journal = {American Journal of Biomedical and Life Sciences}, volume = {2}, number = {2}, pages = {40-45}, doi = {10.11648/j.ajbls.20140202.12}, url = {https://doi.org/10.11648/j.ajbls.20140202.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbls.20140202.12}, abstract = {P. aeruginosa is one of the most important pathogen that causes nosocomial infections often acquired from hospital environment and contaminated medical devices. The infections caused by this bacterium are particularly problematic because it is inherently resistant to several unrelated antimicrobial agents and antiseptics. Hence, the aim of this study was to determine drug resistance and disinfectants susceptibility of P. aeruginosa isolated from clinical samples and hospital environments. A laboratory based cross sectional study was conducted from May to September, 2012 on a total of 81 P. aeruginosa isolates. A standard bacteriological technique (conventional biochemical tests and pigment production) was used to identify the bacterium. Drug resistance and disinfectant susceptibility tests were determined by Kirby-Bauer disc-diffusion and through the classic method of successive dilutions respectively. In this study a total of 305 (160 clinical and 145 environmental) samples were investigated for P. aeruginosa and 81 isolates were obtained. This gives an overall P. aeruginosa isolation rate of 26.5% (81/305). About 47.5% of the clinical and 34.2% environmental isolates were detected from wounds and ward sinks respectively. Of these P. aeruginosa isolates, 95.1% were resistance to Trimethoprim-sulphametoxazole, 62% to Gentamicin, and 58% to Ceftriaxone. But, only 4.9% of isolates were resistance to Amikacin. Moreover, disinfectant susceptibility test revealed that hydrogen peroxide and sodium hypochlorite had a higher (92.6% & 91.4%) bactericidal activity compared to ethanol and savlon at the recommended user dilution. In general, our results indicated that P. aeruginosa was significantly resistance to commonly prescribed antimicrobial drugs, a situation that demands a more rational and appropriate use of antibiotics. Hydrogen peroxide and sodium hypochlorite were relatively more effective when used in recommended dilution. However, all tested disinfectants or antiseptics showed reduced bactericidal activities in higher dilutions. Therefore, strict adherence to the recommended dilution is important for better activity. The correct use of them also has to be considered appropriately as part of infection control practices.}, year = {2014} }
TY - JOUR T1 - Antimicrobial Drug Resistance and Disinfectants Susceptibility of Pseudomonas aeruginosa Isolates from Clinical and Environmental Samples in Jimma University Specialized Hospital, Southwest Ethiopia AU - Meseret Mitiku AU - Solomon Ali AU - Gebre Kibru Y1 - 2014/05/10 PY - 2014 N1 - https://doi.org/10.11648/j.ajbls.20140202.12 DO - 10.11648/j.ajbls.20140202.12 T2 - American Journal of Biomedical and Life Sciences JF - American Journal of Biomedical and Life Sciences JO - American Journal of Biomedical and Life Sciences SP - 40 EP - 45 PB - Science Publishing Group SN - 2330-880X UR - https://doi.org/10.11648/j.ajbls.20140202.12 AB - P. aeruginosa is one of the most important pathogen that causes nosocomial infections often acquired from hospital environment and contaminated medical devices. The infections caused by this bacterium are particularly problematic because it is inherently resistant to several unrelated antimicrobial agents and antiseptics. Hence, the aim of this study was to determine drug resistance and disinfectants susceptibility of P. aeruginosa isolated from clinical samples and hospital environments. A laboratory based cross sectional study was conducted from May to September, 2012 on a total of 81 P. aeruginosa isolates. A standard bacteriological technique (conventional biochemical tests and pigment production) was used to identify the bacterium. Drug resistance and disinfectant susceptibility tests were determined by Kirby-Bauer disc-diffusion and through the classic method of successive dilutions respectively. In this study a total of 305 (160 clinical and 145 environmental) samples were investigated for P. aeruginosa and 81 isolates were obtained. This gives an overall P. aeruginosa isolation rate of 26.5% (81/305). About 47.5% of the clinical and 34.2% environmental isolates were detected from wounds and ward sinks respectively. Of these P. aeruginosa isolates, 95.1% were resistance to Trimethoprim-sulphametoxazole, 62% to Gentamicin, and 58% to Ceftriaxone. But, only 4.9% of isolates were resistance to Amikacin. Moreover, disinfectant susceptibility test revealed that hydrogen peroxide and sodium hypochlorite had a higher (92.6% & 91.4%) bactericidal activity compared to ethanol and savlon at the recommended user dilution. In general, our results indicated that P. aeruginosa was significantly resistance to commonly prescribed antimicrobial drugs, a situation that demands a more rational and appropriate use of antibiotics. Hydrogen peroxide and sodium hypochlorite were relatively more effective when used in recommended dilution. However, all tested disinfectants or antiseptics showed reduced bactericidal activities in higher dilutions. Therefore, strict adherence to the recommended dilution is important for better activity. The correct use of them also has to be considered appropriately as part of infection control practices. VL - 2 IS - 2 ER -